| 產品詳情 |
| Edit |   |
|---|
| Product Name | CCG 203971 |
|---|
| Description | Antifibrotic agent; inhibits fibrosis by targeting the MRTF/SRF gene transcription pathway. Selectively inhibits proliferation of SSc-derived dermal fibroblasts but not that of normal fibroblasts. Inhibits expression of CTGF, α-SMA, and COL1A2 in SSc fibroblasts as well as in LPA and in TGFβ-stimulated fibroblasts. Prevents bleomycin-induced skin thickening and collagen deposition in vivo. Also suppresses PC-3 cell migration in scratch wound assays (IC50 = 4.2 μM). Purity 98%. MW (observed): 408.88 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-(4-Chlorophenyl)-1-[3-(2-furanyl)benzoyl]-3-piperidinecarboxamide |
|---|
| Gene, Accession, CAS # | CAS: 1443437-74-8 |
|---|
| Catalog # | 5277/50 |
|---|
| Price | |
|---|
| Order / More Info | CCG 203971 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 28542204 |
|---|
| 產品資料 |
|
|